Measurable Residual Disease-Guided Therapy for Chronic Lymphocytic Leukemia.

Munir T, Girvan S, Cairns DA, Bloor A, Allsup D, Varghese AM, Gohil S, Paneesha S, Pettitt A, Eyre T, Fox CP, Forconi F, Kennedy B, Balotis C, Pemberton N, Sheehy O, Gribben J, Elmusharaf N, Gatto S, Preston G, Schuh A, Walewska R, Duley L, Webster N, Dalal S, Rawstron A, Howard D, Hockaday A, Jackson S, Greatorex N, Bell S, Stones D, Brown JM, Patten PEM, Hillmen P, UK CLL Trials Group

Open source

DOI: 10.1056/nejmoa2504341
Published: 2025 Sep 25
Container: The New England journal of medicine
Publisher: Not recorded
Open access: unknown

Credibility signals

limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

cautionDOI registered: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
cautionDOI resolves: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredOpen access status: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.1056/nejmoa2504341,
  title = {Measurable Residual Disease-Guided Therapy for Chronic Lymphocytic Leukemia.},
  author = {Munir T and Girvan S and Cairns DA and Bloor A and Allsup D and Varghese AM and Gohil S and Paneesha S and Pettitt A and Eyre T and Fox CP and Forconi F and Kennedy B and Balotis C and Pemberton N and Sheehy O and Gribben J and Elmusharaf N and Gatto S and Preston G and Schuh A and Walewska R and Duley L and Webster N and Dalal S and Rawstron A and Howard D and Hockaday A and Jackson S and Greatorex N and Bell S and Stones D and Brown JM and Patten PEM and Hillmen P and UK CLL Trials Group},
  year = {2025},
  journal = {The New England journal of medicine},
  doi = {10.1056/nejmoa2504341},
  url = {https://doi.org/10.1056/nejmoa2504341}
}

RIS

TY  - JOUR
TI  - Measurable Residual Disease-Guided Therapy for Chronic Lymphocytic Leukemia.
AU  - Munir T
AU  - Girvan S
AU  - Cairns DA
AU  - Bloor A
AU  - Allsup D
AU  - Varghese AM
AU  - Gohil S
AU  - Paneesha S
AU  - Pettitt A
AU  - Eyre T
AU  - Fox CP
AU  - Forconi F
AU  - Kennedy B
AU  - Balotis C
AU  - Pemberton N
AU  - Sheehy O
AU  - Gribben J
AU  - Elmusharaf N
AU  - Gatto S
AU  - Preston G
AU  - Schuh A
AU  - Walewska R
AU  - Duley L
AU  - Webster N
AU  - Dalal S
AU  - Rawstron A
AU  - Howard D
AU  - Hockaday A
AU  - Jackson S
AU  - Greatorex N
AU  - Bell S
AU  - Stones D
AU  - Brown JM
AU  - Patten PEM
AU  - Hillmen P
AU  - UK CLL Trials Group
PY  - 2025
JO  - The New England journal of medicine
DO  - 10.1056/nejmoa2504341
UR  - https://doi.org/10.1056/nejmoa2504341
ER  -

APA

T, M., S, G., DA, C., A, B., D, A., AM, V., S, G., S, P., A, P., T, E., CP, F., F, F., B, K., C, B., N, P., O, S., J, G., N, E., S, G., G, P., A, S., R, W., L, D., N, W., S, D., A, R., D, H., A, H., S, J., N, G., S, B., D, S., JM, B., PEM, P., P, H., & Group, U. C. T. (2025). Measurable Residual Disease-Guided Therapy for Chronic Lymphocytic Leukemia.. The New England journal of medicine. https://doi.org/10.1056/nejmoa2504341

Source records

pubmed · retrieved 2026-09-25T11:25:04.417Z